2 drug suspects shot dead in Calamba City, Antipolo City | Inquirer News

2 drug suspects shot dead in Calamba City, Antipolo City

By: - Correspondent / @dtmallarijrINQ
/ 11:40 AM January 18, 2022

drug suspects, Calamba City and Antipolo City

LUCENA CITY–Two drug suspects were killed in two incidents Monday and Tuesday in Calamba City and Antipolo City.

The Calabarzon (Cavite, Laguna, Batangas, Rizal, Quezon) police reported that Aaron Andaya, 36, was shot dead around 3 a.m. by Cedric Jular, who was accompanied by two others, in Barangay Dos in Calamba City.

Article continues after this advertisement

A report said the victim heard a knock on his door and opened it, after which, and without apparent reason, he was shot by the suspect using a still unknown firearm. The suspect and his unidentified companions escaped after the shooting.

FEATURED STORIES

The report tagged the victim as a “drug personality/surrenderee and a known thief in the area.”

In Antipolo City, Angelo Blarama and Roger Paredes were sitting at a concrete bench around 10 p.m. Monday while playing games with their mobile phones in Barangay Dela Paz.

Article continues after this advertisement

Suddenly, a still-unidentified assailant appeared from behind and shot Blarama twice on his head, killing him on the spot. The gunman left Paredes unharmed.

The police identified Blarama as included on the local police drug watch list.

Both incidents are still under investigation.

lzb
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Antipolo, Calamba, Killings, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.